Quick Answer
HAEMONETICS CORP reported Stockholders Equity of $820.84 million for fiscal year 2025.
HAEMONETICS CORP Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $820.84M | -14.5% |
| 2024 | $959.96M | +17.4% |
| 2023 | $818.00M | +9.2% |
| 2022 | $749.42M | +2.4% |
| 2021 | $731.67M | +24.6% |
| 2020 | $587.11M | -12.1% |
| 2019 | $667.87M | -11.2% |
| 2018 | $752.43M | +1.7% |
| 2017 | $739.61M | +2.5% |
| 2016 | $721.57M | -12.7% |
| 2015 | $826.12M | -1.4% |
| 2014 | $837.89M | +8.9% |
| 2013 | $769.18M | +5.0% |
| 2012 | $732.63M | +6.8% |
| 2011 | $686.14M | +15.7% |
| 2010 | $593.12M | +9.9% |
| 2009 | $539.88M | +9.2% |
| 2008 | $494.19M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $911.45M | +0.5% | +7.3% |
| September 30, 2025 | $849.17M | -3.4% | -3.8% |
| June 30, 2025 | $882.30M | -2.5% | +7.5% |
| March 31, 2025 | $820.84M | -14.5% | -9.5% |
| December 31, 2024 | $906.86M | -3.9% | +3.2% |
| September 30, 2024 | $878.85M | -1.7% | -2.9% |
| June 30, 2024 | $905.37M | +4.7% | -5.7% |
| March 31, 2024 | $959.96M | +17.4% | +1.8% |
- HAEMONETICS CORP showed a decrease of -14.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, HAEMONETICS CORP’s stockholders equity has grown by 66.1% (from $494.19 million to $820.84 million).
- The most recent figure is from HAEMONETICS CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 21, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: